Perhaps an n of 200 would be powered to show a statistically significant difference in survival benefit if RRR is over 35%? Leo could hit their secondary outcome measure if that is the case. Wasn't there a Meta-analysis that showed statistically significant survival benefit even with the heparin arms included?
Market Data 
Markets 
AI
